Why Some Manufacturers Choose Their Own Nursing Partner
Back to All Naven Health NewsFor most specialty therapies, the dispensing pharmacy arranges nursing, and each pharmacy works with its own set of agencies. For a drug distributed through multiple pharmacies, the same manufacturer’s therapy could be administered by dozens of different agencies, each with different training, documentation standards, and therapeutic expertise.
In many scenarios, a manufacturer may have little to no visibility into what happens when a nurse walks through the patient’s front door.
Nursing fragmentation can become a risk
For rare and orphan drugs with small patient populations, it’s important to deliver a strong patient experience every time with highly skilled, compassionate clinical care. Every patient’s experience matters to program outcomes.
A nurse who arrives unfamiliar with the specific therapy requirements creates a problem that no post-visit report can fix. And yet, the default model leaves this to chance.
A new approach with an exclusive nursing partner
Some manufacturers are solving this by selecting and funding a single nursing partner across every patient on the therapy, regardless of which pharmacy dispenses the drug.
Naven Health has operated in this model for a rare and orphan pediatric therapy for four years. Because the manufacturer pays for nursing directly. Every patient sees a nurse trained on the drug’s specific protocols. A dedicated program management team ensures consistency at every visit. And reporting flows directly to providers and the manufacturer.
In four years, we’ve accomplished 370+ visits, 0% Naven-attributable cancellation rate, and maintained 100% patient satisfaction.
Delivering a more consistent experience
Any therapy where the point-of-care experience directly affects adherence is worth exploring this model to ensure you are delivering an experience that best serves your brand.
Manufacturers invest heavily in development, regulatory strategy, and commercial launch. Don’t let the nurse who administers the drug in a patient’s home be a step left to chance.
Download the case study to learn more about Naven Health’s Exclusive Nursing Program for R&O Therapy.
Naven News
Helping Patients Learn to Self-Administer in a Commercial Teach and Train Program
For patients managing a rare disease, learning to self-administer therapy at home can be a turning point. Perhaps creating fewer clinic visits, fewer disruptions to daily life, and a sense of control over a condition that often feels uncontrollable. Reaching that level of independence can be supported with in-home nursing services to teach and empower […]
Helping Your Patients Initiate Therapy, Faster: Nursing Care for Your Quick Start Program
When a patient is prescribed a new specialty therapy, the clock starts. Every day between prescribed and first dose is a day the patient lives without treatment, and for patients managing complex conditions, that gap carries real consequences. Most of the time, the delay has nothing to do with clinical readiness. The physician has sent […]
